Prestige Consumer Healthcare Inc. (PBH) stock
Close on Nov 17, 2026Market cap $2.28BP/E 13.5Yield –
Prestige Consumer Healthcare Inc. saw revenue fall 1.4% to $1.10B over the twelve months to Jun 30, 2026. Operating income fell 13.8% to $290.17M, moving the operating margin from 30.0% to 26.3%. Free cash flow was $235.36M, down 12.1% from a year earlier. At the latest close the market valued the company at $2.28B, 13.5 times its earnings.
Key statistics
Valuation at the latest close; fundamentals over the trailing twelve months, balances at Jun 30, 2026
Valuation
- Market cap
- $2.28B
- P/E ratio
- 13.5
- Price to sales
- 2.07
- Price to book
- 1.19
- Dividend yield
- –
- Free cash flow yield
- 10.30%
Fundamentals
- Revenue
- $1.10B
- Net income
- $172.01M
- EPS, diluted
- $3.57
- Free cash flow
- $235.36M
- Book value per share
- $40.26
- Diluted shares
- 48M
Trading
- Next earnings
- Feb 4, 2027 (estimated, before the open)
- Previous close
- $48.00
- Open
- $47.59
- Day's range
- $47.43 – $48.79
- Volume
- 597,840
- Average volume (20 days)
- 629,150
- Index membership
- S&P SmallCap 600 (since Feb 2021), Russell 2000, Russell 3000
- 52-week range
- $41.77 – $71.07
- RSI (14 days)
- 52.9
- Volatility (1 year)
- 38.1%
- Relative volume
- 1.06×
On 1 of our idea list: Buyback cannibals
Index membership is inferred from the holdings of funds that track each index (SPSM, IJR, IWM, IWV), as reported to the SEC for Jun 30, 2026. Join dates come from quarterly fund reports since 2019, so they are accurate to the quarter.
Market cap history
Month-end market cap since 2010, using shares outstanding reported at the time
Total return vs. the S&P 500
Price change plus reinvested dividends, to the close on Nov 17, 2026. The S&P 500 is measured by the SPY fund.
| Period | PBH | S&P 500 | Difference | PBH per year | S&P 500 per year |
|---|---|---|---|---|---|
| 1 month | -3.4% | -4.0% | +0.6 pts | ||
| 3 months | -3.6% | -5.0% | +1.3 pts | ||
| Year to date | -21.8% | +8.2% | −30.1 pts | ||
| 1 year | -18.2% | +11.2% | −29.5 pts | ||
| 3 years | -17.3% | +68.5% | −85.8 pts | -6.1% | +19.0% |
| 5 years | -20.9% | +67.3% | −88.2 pts | -4.6% | +10.8% |
| 10 years | -4.2% | +291.6% | −295.8 pts | -0.4% | +14.6% |
Fifteen years at a glance
Fiscal years 2012 to 2026 and trailing twelve months, USD
Revenue
Gross profit
Operating income
Net income
EPS, diluted
Free cash flow
Press releases
Releases Prestige Consumer Healthcare filed with the SEC as exhibits to Form 8-K or 6-K
- Results
- Results
- Results
- Results
- Update
- Update
About Prestige Consumer Healthcare
Pharmaceutical Preparations
Prestige Consumer Healthcare Inc. develops, manufactures, markets, and distributes over-the-counter healthcare and personal care products. The company's offerings include pain relievers, gastrointestinal remedies, sore throat medications, eye and ear care items, dermatological treatments, oral care products, and feminine hygiene supplies. It organizes operations into two reporting segments: North American OTC Healthcare and International OTC Healthcare. Its customers consist of retail and wholesale businesses, including mass merchandisers, drugstores, supermarkets, dollar and convenience stores, club stores, and e-commerce merchants.
Company profile, executives and historyPrestige Consumer Healthcare stock: common questions
What is Prestige Consumer Healthcare's stock price?
PBH closed at $48.22 on Nov 17, 2026, up 0.46% on the day. Over the past 52 weeks it traded between $41.77 and $71.07.
What is Prestige Consumer Healthcare's market cap?
Prestige Consumer Healthcare was worth $2.28B at the close on Nov 17, 2026: the share price times the diluted shares outstanding.
What is PBH's P/E ratio?
PBH trades at 13.5 times earnings, based on diluted earnings per share of $3.57 over the twelve months to Jun 30, 2026.
How much revenue does Prestige Consumer Healthcare make?
Prestige Consumer Healthcare reported revenue of $1.10B for the twelve months to Jun 30, 2026, down 1.4% from a year earlier.
Does Prestige Consumer Healthcare pay a dividend?
No. Prestige Consumer Healthcare has not paid a cash dividend over the last twelve months.
When does Prestige Consumer Healthcare report earnings next?
Prestige Consumer Healthcare is expected to report Q3 FY2027 results on Feb 4, 2027, before the open. The date is estimated from its past reporting pattern until the company confirms it.
How has PBH stock performed over the past year?
Including dividends, PBH returned -18.2% over the past year, against +11.2% for the S&P 500.
How many PBH shares are sold short?
4M shares were sold short at the latest FINRA report, 9.09% of the float, or 8.1 days of average trading volume.
Who are Prestige Consumer Healthcare's competitors?
Companies most similar to Prestige Consumer Healthcare by business, industry and size include PRGO, PAHC, AMRX, ANIP, NATR.
See a number that looks wrong?